Search Results 1751-1760 of 17069 for monoclonal antibody

1. A Study of the Safety and Effectiveness of Atezolizumab Combined with Etoposide, and Carboplatin for Patients with Untreated Extensive-Stage Small Cell Lung Cancer - Mayo Clinic

   Prior treatment with cluster of differentiation 137 (CD137) agonists or immune checkpoint blockade therapies, anti-PD1, and anti-PD-L1 therapeutic antibody ...

2. Diphtheria, tetanus, acellular pertussis, polio vaccine (intramuscular route) - Mayo Clinic

   The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given only to children 4 to 6 years ...

3. Clinical trials - Oncology (Medical)

   UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an ...

4. Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab - Mayo Clinic

   ... antibodies). New onset or signs and symptoms of any form of ... Prior exposure to any anti-IgE antibody therapy other than omalizumab and ligelizumab.

5. A Phase 1/2 Study to Evaluate MEDI4736 - Clinical Trials

   Prior exposure to any anti-PD-1 or anti-PD-L1 antibody; Any concurrent chemotherapy, immunotherapy, biologic or hormonal therapy for cancer treatment. Prior ...

6. Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial - Mayo Clinic

   ... antibody and/or small molecule treatment is allowed, except for PARP inhibitors). Life expectancy >6 months; ECOG performance status 0 or 1. (Form is ...

7. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Diagnosis of smoldering MM, Waldenström's macroglobulinemia, POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) ...

8. Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer - Mayo Clinic

   Patients with a history of prior treatment with anti-PD-1, anti-PD-L1, anti-PDL2, anti- CTLA-4 antibodies, other checkpoint inhibitors. Other protocol ...

9. A Study to Evaluate the Effectiveness and Safety of PRV-015 in Adult Patients wth Non-responsive Celiac Disease as an Adjunct to a Gluten-free Diet - Mayo Clinic

   Must have detectable (above the lower limit of detection) serum celiac-related antibodies. Must have human leukocyte antigen DQ (HLA-DQ) typing consistent ...

10. A Study to Evaluate Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients with Dyskeratosis Congenita - Mayo Clinic

    Positive patient anti-donor HLA antibody, which is deemed clinically significant. Prior allogeneic marrow or stem cell transplantation. Prior solid organ ...